Effect of Dapagliflozin, Metformin and Physical Activity on Glucose Variability, Body Composition and Cardiovascular Risk in Pre-diabetes
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Pre-D
- 07 Jun 2017 Biomarkers information updated
- 12 Aug 2016 Planned number of patients changed from 160 to 120.
- 12 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Feb 2019.